期刊文献+

RP-HPLC法测定人血浆中扎来普隆浓度 被引量:3

Determination of Zaleplon in Human Plasma by RP - HPLC with Fluorescence Detection
下载PDF
导出
摘要 目的:建立测定人血浆中扎来普隆浓度的反相高效液相色谱法。方法:血浆样品中加入内标β-萘酚后用乙酸乙酯提取。固定相为Supelcosil C8色谱柱(250 mm ×4.6 mm,5μm),流动相为0.04 mol·L-1磷酸二氢钾缓冲液-乙腈(6:5,含三乙胺0.3%,磷酸调至pH 5.0),流速为1.0 mL·min-1。荧光检测:荧光激发波长345nm,发射波长460 nm。结果:本方法线性范围为1-128 ng·mL-1(r=0.9995),最低检测浓度为0.2 ng·mL-1,提取回收率为87.4%-91.9%,方法回收率为98.8%-100.8%,日内RSD为2.9%-5.4%,日间RSD为3.8%-13.3%。结论:本法简便、准确,适用于扎来普隆药代动力学的研究。 Objective: An RP - HPLC method was established for the determination of zaleplon in human plasma. Methods: After addition of β- naphthol (internal standard ) , zaleplon in plasma samples was extracted with ethyl acetate and determined by RP - HPLC. The analysis involved a 250 mm×4. 6 mm column packed with Supelcosil C8 (5 μm). The mobile phase consisted of 0. 04 mol·L-1 potassium dihydrogen phosphate solution - acetonitrile (6 :5,contained triethylamine 0. 3% ,adjusted to pH 5. 0 with phosphoric acid) with a flow rate of 1. 0 mL·min-1. The fluorescence detector was set at Ex 345 nm and Em 460 nm. Results:The linear range was of 1 - 128 ng·mL-1 ( r= 0. 9995 ). The minimal detectable concentration was 0. 2 ng·mL-1. The extraction recovery was 87. 4% -91. 9%. The method recovery was 98. 8% - 100. 8% . Within - day RSD was 2. 9% -5. 4% . Between - day RSDwas 3. 8% - 13. 3%. Conclusion: The method is simple and accurate, which is suitable for the pharmacokinetic study of zaleplon.
出处 《药物分析杂志》 CAS CSCD 北大核心 2004年第6期611-613,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 RP-HPLC法 测定 扎来普隆 药代动力学 zaleplon, RP - HPLC, fluorescence detection
  • 相关文献

参考文献2

  • 1Beer B, leni JR, Wu WH, et al. A placebo - controlled evaluation of single, escalating doses of CL 284,846, a non - benzodiazepine hypnotic. J Clin Pharmacol , 1994,34 : 335
  • 2戴敏,杨菁菁,裘福荣,孙华,冒国光,钟秋,陈波.扎莱普隆胶囊的相对生物利用度研究[J].中国临床药理学杂志,2002,18(2):133-136. 被引量:5

二级参考文献3

  • 1[3]Beer B,Ieni JR,Wu WH,et al.A Placebo-Controlled Evaluation of Single,Escalating Doses of CL 284,846,a Non-Benzodiazepine Hypnotic.J Clinical Pharmacology.1994:34:335~344.
  • 2[1]Greenblatt DJ,Harmatz JS,von Moltke LL,et al.Comparative kinetics and dynamics of zaleplon,zolpidem,and placebo.Clinical Pharmacology Therapeutics,1998;64:553~561.
  • 3[2]Gaudreault J,Varin F,Pollack GM.Pharmacokinetics and Anticonvulsant Effect of a New Hypnotic.CL 284,846,in Rats.Pharmaceutical Research,1995; 12:1592~1597.

共引文献4

同被引文献24

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部